DOC Pharma has been a key player in the Italian pharmaceutical sector since 1996. With an IQVIA 2023 ex-factory revenue of €299 million, DOC ranks eighth in value among pharmaceutical companies in Italy and second in the Class A generic drug market (IQVIA data). DOC is also among the top five companies in the generic drug sector by revenue, holding a market share of approximately 19%.
Over the years, we have embarked on a path of growth and expansion—through acquisitions and process innovation—broadening our coverage across multiple therapeutic areas and offering a diverse range of healthcare solutions. This has strengthened our role in making healthcare accessible to all.
DOC has consistently stood out for its commitment to excellence, positioning itself as a trusted partner for doctors, pharmacists, and millions of patients—empowering them to make better, more informed choices. Because the choices we make every day shape who we become.
Company Details
- Employees
- 350
- Founded
- -
- Address
- Via Turati 40, Milano,mi 20124,italy
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://docpharma.com
- HQ
- Milano, Mi
Doc Pharma Official Questions
Doc Pharma Official's website is https://docpharma.com
Doc Pharma Official's LinkedIn profile is https://it.linkedin.com/company/doc-pharma-official
Doc Pharma Official has
350 employees.
View email and phone details for 350
employees at Doc Pharma Official.
Doc Pharma Official's industry is
Pharmaceutical Manufacturing
Doc Pharma Official's top competitors are
Menarini Group,
Alfasigma,
Italfarmaco S.p.a.,
Ibsa Italy,
Angelini Pharma,
Eg Italia Gruppo Stada,
Dompé,
Fidia Pharma,
Sandoz Italia,
Zentiva Italia.
Doc Pharma Official's categories are Pharmaceutical Manufacturing
Doc Pharma Official's founding year is 1996
